Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 3
1965 2
1966 11
1967 11
1968 14
1969 10
1970 7
1971 15
1972 16
1973 18
1974 13
1975 9
1976 14
1977 13
1978 15
1979 9
1980 11
1981 9
1982 7
1983 11
1984 11
1985 14
1986 8
1987 10
1988 4
1989 20
1990 7
1991 9
1992 6
1993 6
1994 11
1995 9
1996 14
1997 15
1998 17
1999 13
2000 17
2001 17
2002 11
2003 17
2004 9
2005 17
2006 16
2007 22
2008 26
2009 20
2010 26
2011 31
2012 34
2013 33
2014 26
2015 16
2016 20
2017 15
2018 13
2019 14
2020 14
2021 9
2022 9
2023 9
2024 13
2025 9
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

785 results

Results by year

Filters applied: . Clear all
Page 1
Modafinil Versus Amphetamine-Dextroamphetamine For Idiopathic Hypersomnia and Narcolepsy Type 2: A Randomized, Blinded, Non-inferiority Trial.
Trotti LM, Blake T, Hoque R, Rye DB, Sharma S, Bliwise DL. Trotti LM, et al. CNS Drugs. 2024 Nov;38(11):909-920. doi: 10.1007/s40263-024-01122-y. Epub 2024 Sep 21. CNS Drugs. 2024. PMID: 39306601 Free PMC article. Clinical Trial.
We performed a randomized, fully blinded, noninferiority trial of modafinil versus amphetamine-dextroamphetamine in these disorders. METHODS: Forty-four adults were randomized to modafinil or amphetamine-dextroamphetamine, individually titrated to a maximum of modaf …
We performed a randomized, fully blinded, noninferiority trial of modafinil versus amphetamine-dextroamphetamine in these disorders. …
Dextroamphetamine-morphine analgesia.
[No authors listed] [No authors listed] N Engl J Med. 1977 Jul 14;297(2):115-6. doi: 10.1056/NEJM197707142970218. N Engl J Med. 1977. PMID: 325410 Clinical Trial. No abstract available.
Amphetamine abuse.
Ellinwood EH, Cohen S. Ellinwood EH, et al. Science. 1971 Jan 29;171(3969):420-1. doi: 10.1126/science.171.3969.420. Science. 1971. PMID: 4923360 Clinical Trial. No abstract available.
Effect of Dextroamphetamine on Poststroke Motor Recovery: A Randomized Clinical Trial.
Goldstein LB, Lennihan L, Rabadi MJ, Good DC, Reding MJ, Dromerick AW, Samsa GP, Pura J. Goldstein LB, et al. JAMA Neurol. 2018 Dec 1;75(12):1494-1501. doi: 10.1001/jamaneurol.2018.2338. JAMA Neurol. 2018. PMID: 30167675 Free PMC article. Clinical Trial.
IMPORTANCE: Data from animal models show that the administration of dextroamphetamine combined with task-relevant training facilitates recovery after focal brain injury. ...RESULTS: Among the 64 patients randomized to dextroamphetamine vs placebo (55% men; median ag …
IMPORTANCE: Data from animal models show that the administration of dextroamphetamine combined with task-relevant training facilitate …
Clinical gains from including both dextroamphetamine and methylphenidate in stimulant trials.
Ramtvedt BE, Røinås E, Aabech HS, Sundet KS. Ramtvedt BE, et al. J Child Adolesc Psychopharmacol. 2013 Nov;23(9):597-604. doi: 10.1089/cap.2012.0085. Epub 2013 May 9. J Child Adolesc Psychopharmacol. 2013. PMID: 23659360 Free PMC article. Clinical Trial.
OBJECTIVE: The purpose of this study was to investigate clinical gains from including both dextroamphetamine and methylphenidate in stimulant trials. METHOD: Thirty-six medication-naive children ages 9-14 years diagnosed with attention-deficit/hyperactivity disorder (ADHD) …
OBJECTIVE: The purpose of this study was to investigate clinical gains from including both dextroamphetamine and methylphenidate in s …
Minimizing adverse events while maintaining clinical improvement in a pediatric attention-deficit/hyperactivity disorder crossover trial with dextroamphetamine and methylphenidate.
Ramtvedt BE, Aabech HS, Sundet K. Ramtvedt BE, et al. J Child Adolesc Psychopharmacol. 2014 Apr;24(3):130-9. doi: 10.1089/cap.2013.0114. Epub 2014 Mar 25. J Child Adolesc Psychopharmacol. 2014. PMID: 24666268 Free PMC article. Clinical Trial.
No significant increase from placebo to stimulant conditions was detected on SERS items reflecting emotional symptoms. Furthermore, dextroamphetamine and methylphenidate did not differ from each other on any SERS item, except that dextroamphetamine was associated wi …
No significant increase from placebo to stimulant conditions was detected on SERS items reflecting emotional symptoms. Furthermore, dextr …
Amphetamine-induced dopamine release and impulsivity in Parkinson's disease.
Song AK, Hay KR, Trujillo P, Aumann M, Stark AJ, Yan Y, Kang H, Donahue MJ, Zald DH, Claassen DO. Song AK, et al. Brain. 2022 Oct 21;145(10):3488-3499. doi: 10.1093/brain/awab487. Brain. 2022. PMID: 34951464 Free PMC article. Clinical Trial.
Twenty patients with Parkinson's disease (mean age = 64.1 5.8 years) both with (n = 10) and without (n = 10) impulsive-compulsive behaviours, participated in a single-blind dextroamphetamine challenge (oral; 0.43 mg/kg) in an OFF dopamine state. All completed PET imaging w …
Twenty patients with Parkinson's disease (mean age = 64.1 5.8 years) both with (n = 10) and without (n = 10) impulsive-compulsive behaviours …
Effects of nefopam on visual tracking.
Belleville JP, Dorey F, BEllville JW. Belleville JP, et al. Clin Pharmacol Ther. 1979 Oct;26(4):457-63. doi: 10.1002/cpt1979264457. Clin Pharmacol Ther. 1979. PMID: 487693 Clinical Trial.
785 results